同步双栓治疗51例肝癌  

Treatment of the Liver Cancer by Dual Intravascular Embolization Chemotherapy

作　　者：宋蔚青[1] 何曙生[1] 李晓明[1] 张继光 卢云[1] 

机构地区：[1]西安医科大学第一附属医院肝胆外科,陕西省肿瘤研究所

出　　处：《中国肿瘤临床》1996年第8期565-568,共4页Chinese Journal of Clinical Oncology

摘　　要：经腹置管同步双相化疗栓塞术是治疗肝癌的一种新方法。临床应用５１例，经临床实践和肝储备功能的监测，作者认为该疗法具有操作简单、安全可靠、术后并发症少、疗效确切的特点。１年生存率３４／５１（６６．６％），２年生存率１６／５１（３１．３％），３例超过３年。本文简要讨论应用的基本理论，置管方法和其优点。提示该方法适合我国目前国情，是综合治疗肝癌的有效方法之一。Dual embolization via hepatic artery and portal vein simultaneously is a new approach in the treatment of hepatocellular carcinoma.Fifty-one cases were treated.The overall survival rate at 1 year was 66.6%(34/51),at 2 year was 31.3%(16/51)and 3 cases survived over three years.This procedure didn't resulted from the embolization could be compensated completely.The method is simple,safe and moe effective than single TAE for advanced liver cancer.

关 键 词：肝肿瘤 药物疗法 同步双栓 

分 类 号：R735.705[医药卫生—肿瘤]